Article
Tofacitinib for the treatment of psoriasis
8 Jun 2016
Abstract excerpt
INTRODUCTION: The identification of a number of psoriasis-susceptibility genes and a better understanding of the pathogenesis of the intracellular metabolic pathways, have generated new perspectives on psoriasis treatment, in particular new compounds that inhibit certain intracellular proteins involved in the immune response. In contrast to biologic agents, these compounds block intracellular targets such as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
